
Italy Biopharmaceutical market Valuation Expected to Hit USD 23.2 billion by Key Players: Novartis (Italy operations), Roche Italia, Pfizer Italia
USA, New Jersey: According to Verified Market Research analysis, the global Italy Biopharmaceutical Market size is reached a valuation of USD 8.5 Billion in 2024, with projections to achieve USD 23.2 Billion by 2032, demonstrating a CAGR 11.8% from 2024
%2FMicrosoft%2520Corporation%2520logo%2520on%2520sign-by%2520Jean-Luc%2520Ichard%2520via%2520iStock.jpg)







